Medicine and Dentistry
Combination Therapy
100%
Alpha Adrenergic Receptor Blocking Agent
50%
Parasympatholytic
37%
Man
33%
Quality of Life
33%
Adverse Event
25%
Lower Urinary Tract Symptom
25%
Obstruction
25%
Monotherapy
20%
Symptom
20%
Random Effects Model
12%
Age
12%
Randomized Controlled Trial
8%
Surgery
4%
Spinal Cord Injury
4%
International Prostate Symptom Score
4%
Multiple Sclerosis
4%
Central Nervous System Disease
4%
Neurogenic Bladder
4%
Analysis
4%
Language
4%
Systematic Review
4%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
91%
Alpha Adrenergic Receptor Blocking Agent
50%
Placebo
50%
Cholinergic Receptor Blocking Agent
37%
Adverse Event
25%
Obstruction
25%
Lower Urinary Tract Symptom
25%
Monotherapy
20%
Symptom
20%
Spinal Cord Injury
4%
Multiple Sclerosis
4%
Central Nervous System Disease
4%
Neurogenic Bladder
4%
Biochemistry, Genetics and Molecular Biology
Alpha Blocker
50%
Anticholinergic
33%
Life
16%
Age
12%
Cochrane Library
4%
Embase
4%
Taxonomy
4%
Language
4%
Neuroscience
Alpha Blocker
50%
Anticholinergic
33%
Placebo
25%
Randomized Controlled Trial
4%
Spinal Cord Injury
4%
Multiple Sclerosis
4%
Central Nervous System Disease
4%
Psychology
Groups
12%
Main Result
4%
Systematic Literature Review
4%
Spinal Cord Injury
4%
Inclusion
4%
Data Collection
4%
Biases
4%
Inconsistencies
4%
Neurological System
4%